ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Moment of Clarity Explores TMS Therapy for PTSD in New Resource

RESEDA, CA - October 23, 2025 - PRESSADVANTAGE -

Moment of Clarity has released a new resource titled "What to Know About TMS Therapy for PTSD", now available on their website. The article provides an overview of how transcranial magnetic stimulation (TMS) may benefit patients experiencing post-traumatic stress disorder (PTSD), while also highlighting how this advanced therapy can be integrated into trauma-informed mental health programs. The publication is designed to provide patients and their families with clear, evidence-based information as they consider treatment options.

PTSD is a complex condition that develops after exposure to trauma, with symptoms that may include flashbacks, hypervigilance, and emotional distress. Traditional approaches such as psychotherapy and medication help many patients, but some continue to struggle with persistent symptoms. The article explains that TMS, a non-invasive procedure that uses magnetic pulses to stimulate specific regions of the brain, is being studied as an alternative for patients whose PTSD has not responded fully to conventional care.

Autism Treatment Reseda, California at Moment of Clarity

The resource clarifies that TMS is FDA-approved for treatment-resistant depression and obsessive-compulsive disorder, but its application for PTSD is considered off-label. Clinical research, including studies published in Biological Psychiatry and The Journal of Affective Disorders, has yielded promising results, with some patients reporting a reduction in symptom severity and an improvement in quality of life. However, further large-scale trials are needed before regulatory approval for PTSD is possible.

The publication situates TMS within a broader framework of integrated care. PTSD often co-occurs with conditions such as depression, anxiety, or substance use disorders. For patients in Reseda, combining trauma-focused counseling, psychiatric evaluation, and dual diagnosis services with advanced treatments like TMS provides a more comprehensive pathway to recovery. The article emphasizes that TMS is not a replacement for evidence-based therapies, such as CBT or EMDR, but rather a complementary approach that may enhance the effectiveness of those therapies by stabilizing mood and reducing symptom intensity.

Addressing co-occurring disorders is another focus of the resource. Many patients living with PTSD also face challenges such as addiction or bipolar disorder. Treating one condition without the other often leads to relapse or incomplete recovery. By explaining how dual diagnosis mental health programs integrate services like TMS, medication management, and trauma therapy, the article reinforces the importance of holistic, patient-centered planning.

Safety and accessibility are also highlighted. TMS is described as noninvasive, generally well-tolerated, and delivered in outpatient settings. Side effects are typically mild, including temporary scalp discomfort or headaches, and most patients resume daily activities immediately after treatment. For families who may be cautious about trying new therapies, the article notes that TMS has a well-established safety record in depression care and is delivered under strict medical supervision.

Stigma is another barrier to care that the publication addresses. Many people delay treatment for PTSD due to fear of judgment or misunderstanding. By presenting TMS as a research-supported option within comprehensive treatment programs, the article helps normalize the pursuit of advanced therapies and encourages earlier engagement with care.

Moment of Clarity also stresses that recovery from PTSD is not linear. Patients may transition between therapies or adjust their treatment plans based on their progress. TMS can play a role in this evolving process by reducing the intensity of symptoms, thereby enabling patients to participate more effectively in counseling and skills-based therapies.

By publishing What to Know About TMS Therapy for PTSD, Moment of Clarity provides transparent, evidence-informed education for patients and families. The resource explains what TMS is, how it may benefit people with PTSD, its current regulatory status, and how it fits into a continuum of care that includes trauma-informed substance abuse treatment, dual diagnosis services, and evidence-based counseling.

For individuals in Reseda, California seeking clear information about advanced therapies, this resource provides a balanced perspective. By separating what is known from what is still under study, Moment of Clarity equips patients and families with the knowledge they need to make informed choices about treatment and to approach recovery with greater confidence.

https://www.youtube.com/shorts/6TXiqZ-rMX0

###

For more information about Moment of Clarity Reseda, contact the company here:

Moment of Clarity Reseda
Marie Mello
(747) 337-3075
marie@momentofclarity.com
18617 Keswick St, Reseda, CA 91335

Recent Quotes

View More
Symbol Price Change (%)
AMZN  248.40
+0.00 (0.00%)
AAPL  269.43
+0.00 (0.00%)
AMD  243.98
+0.00 (0.00%)
BAC  53.42
+0.00 (0.00%)
GOOG  290.59
+0.00 (0.00%)
META  631.76
+0.00 (0.00%)
MSFT  506.00
+0.00 (0.00%)
NVDA  199.05
+0.00 (0.00%)
ORCL  240.83
+0.00 (0.00%)
TSLA  445.23
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.